Novartis Investigative Site
Yangzhou, Jiangsu 225001
0 studies enrolling now · 1 studies all time
What they study most
Autoimmunity, Inflammation
Studies at this site
- Secukinumab Open Label Roll-over Extension Protocol — Recruiting now
Yangzhou, Jiangsu 225001
0 studies enrolling now · 1 studies all time
Autoimmunity, Inflammation